BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19883627)

  • 1. miR-139 impacts FoxO1 action by decreasing FoxO1 protein in mouse hepatocytes.
    Hasseine LK; Hinault C; Lebrun P; Gautier N; Paul-Bellon R; Van Obberghen E
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1278-82. PubMed ID: 19883627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear forkhead box O1 controls and integrates key signaling pathways in hepatocytes.
    Naïmi M; Gautier N; Chaussade C; Valverde AM; Accili D; Van Obberghen E
    Endocrinology; 2007 May; 148(5):2424-34. PubMed ID: 17303659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human-specific microRNA regulation of FOXO1: implications for microRNA recognition element evolution.
    McLoughlin HS; Wan J; Spengler RM; Xing Y; Davidson BL
    Hum Mol Genet; 2014 May; 23(10):2593-603. PubMed ID: 24368418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1.
    Luo A; Yan H; Liang J; Du C; Zhao X; Sun L; Chen Y
    Gene; 2017 Sep; 627():194-201. PubMed ID: 28627440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The coactivator p300 directly acetylates the forkhead transcription factor Foxo1 and stimulates Foxo1-induced transcription.
    Perrot V; Rechler MM
    Mol Endocrinol; 2005 Sep; 19(9):2283-98. PubMed ID: 15890677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-223 regulates FOXO1 expression and cell proliferation.
    Wu L; Li H; Jia CY; Cheng W; Yu M; Peng M; Zhu Y; Zhao Q; Dong YW; Shao K; Wu A; Wu XZ
    FEBS Lett; 2012 Apr; 586(7):1038-43. PubMed ID: 22569260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MiR-135b promotes proliferation of endometrial carcinoma cells by targeting FOXO1].
    Yue Z; Shen JJ; Huang QT; Qin YF; Li XN; Liu GB
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 May; 36(5):675-80. PubMed ID: 27222184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA HIPK3 contributes to hyperglycemia and insulin homeostasis by sponging miR-192-5p and upregulating transcription factor forkhead box O1.
    Cai H; Jiang Z; Yang X; Lin J; Cai Q; Li X
    Endocr J; 2020 Apr; 67(4):397-408. PubMed ID: 31875589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-182 is a negative regulator of osteoblast proliferation, differentiation, and skeletogenesis through targeting FoxO1.
    Kim KM; Park SJ; Jung SH; Kim EJ; Jogeswar G; Ajita J; Rhee Y; Kim CH; Lim SK
    J Bone Miner Res; 2012 Aug; 27(8):1669-79. PubMed ID: 22431396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXO1-mediated epigenetic modifications are involved in the insulin-mediated repression of hepatocyte aquaporin 9 expression.
    Qiu LW; Gu LY; Lü L; Chen XF; Li CF; Mei ZC
    Mol Med Rep; 2015 Apr; 11(4):3064-8. PubMed ID: 25503267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of miR-96 expression reduces cell proliferation and clonogenicity of HepG2 hepatoma cells.
    Xu D; He X; Chang Y; Xu C; Jiang X; Sun S; Lin J
    Oncol Rep; 2013 Feb; 29(2):653-61. PubMed ID: 23151657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-542-5p Inhibits Hyperglycemia and Hyperlipoidemia by Targeting FOXO1 in the Liver.
    Tian F; Ying HM; Wang YY; Cheng BN; Chen J
    Yonsei Med J; 2020 Sep; 61(9):780-788. PubMed ID: 32882762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translocation of forkhead box O1 to the nuclear periphery induces histone modifications that regulate transcriptional repression of PCK1 in HepG2 cells.
    Arai T; Kano F; Murata M
    Genes Cells; 2015 Apr; 20(4):340-57. PubMed ID: 25736587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells.
    Guttilla IK; White BA
    J Biol Chem; 2009 Aug; 284(35):23204-16. PubMed ID: 19574223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction.
    Puigserver P; Rhee J; Donovan J; Walkey CJ; Yoon JC; Oriente F; Kitamura Y; Altomonte J; Dong H; Accili D; Spiegelman BM
    Nature; 2003 May; 423(6939):550-5. PubMed ID: 12754525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated expression of forkhead box protein O1 (FoxO1) in alcohol-induced intestinal barrier dysfunction.
    Wang Y; Tong J; Zou D; Chang B; Wang B; Wang B
    Acta Histochem; 2013 Jul; 115(6):557-63. PubMed ID: 23347700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGA1 is a novel transcriptional regulator of the FoxO1 gene.
    Arcidiacono B; Chiefari E; Messineo S; Bilotta FL; Pastore I; Corigliano DM; Foti DP; Brunetti A
    Endocrine; 2018 Apr; 60(1):56-64. PubMed ID: 29052178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver.
    Matsumoto M; Pocai A; Rossetti L; Depinho RA; Accili D
    Cell Metab; 2007 Sep; 6(3):208-16. PubMed ID: 17767907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus differentially modulates activation of forkhead transcription factors and insulin-induced metabolic gene expression.
    Banerjee A; Meyer K; Mazumdar B; Ray RB; Ray R
    J Virol; 2010 Jun; 84(12):5936-46. PubMed ID: 20357092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis.
    Valenti L; Rametta R; Dongiovanni P; Maggioni M; Fracanzani AL; Zappa M; Lattuada E; Roviaro G; Fargion S
    Diabetes; 2008 May; 57(5):1355-62. PubMed ID: 18316359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.